Welcome to CDC Stacks | Leishmaniasis, Autoimmune Rheumatic Disease, and Anti–Tumor Necrosis Factor Therapy, Europe - 17824 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Leishmaniasis, Autoimmune Rheumatic Disease, and Anti–Tumor Necrosis Factor Therapy, Europe
  • Published Date:
    Jun 2009
  • Source:
    Emerg Infect Dis. 15(6):956-959.
Filetype[PDF - 496.57 KB]


Details:
No Related Documents.
You May Also Like:
  1. Nontuberculous Mycobacteria Infections and Anti–Tumor Necrosis Factor-α Therapy
    Personal Author:
    Winthrop, Kevin L.; Chang, Eric; Yamashita, Shellie; Iademarco, Michael F.; LoBue, Philip A.;
    Published:
    Oct 2009
    Source:
    Emerg Infect Dis. 15(10):1556-1561.
    Description:
    Patients receiving anti-tumor necrosis factor-alpha (anti-TNF-alpha) therapy are at increased risk for tuberculosis and other granulomatous diseases, but little is known about illness caused by nontuberculous mycobacteria (NTM) in this setting. We re...
    File Type:
    Filetype[PDF - 425.15 KB]
  2. Nontuberculous Mycobacterium Infection and Tumor Necrosis Factor-α Antagonists
    Personal Author:
    Swart, Reinout M.; van Ingen, Jakko; van Soolingen, Dick; Slingerland, Rob; Hendriks, Willem D.H.; den Hollander, Jan G.;
    Published:
    Oct 2009
    Source:
    Emerg Infect Dis. 15(10):1700-1701.
    File Type:
    Filetype[PDF - 353.56 KB]
  3. Rheumatic autoimmune diseases in women and midlife health
    Personal Author:
    Marder, Wendy; Vinet, Évelyne; Somers, Emily C.;
    Published:
    Dec 02 2015
    Source:
    Womens Midlife Health. 1.
    Description:
    Autoimmune diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and systemic sclerosis (scleroderma) preferentially affect women, and are characterized by systemic inflammation leading to target organ dysfunction. The publi...
    File Type:
    Filetype[PDF - 355.43 KB]
  4. Tumor necrosis factor receptors 1 and 2 are associated with early glomerular lesions in type 2 diabetes
    Personal Author:
    Pavkov, Meda E.; Weil, E. Jennifer; Fufaa, Gudeta D.; Nelson, Robert G.; Lemley, Kevin V.; Knowler, William C.; Niewczas, Monika A.; Krolewski, Andrzej S.;
    Published:
    Jan 04 2016
    Source:
    Kidney Int. 89(1):226-234.
    Description:
    Elevated serum tumor necrosis factor receptor 1 (TNFR1) and 2 (TNFR2) concentrations are strongly associated with increased risk of end-stage renal disease in type 2 diabetes. However, little is known about the early glomerular structural lesions tha...
    File Type:
    Filetype[PDF - 306.74 KB]
  5. Tuberculosis Associated with Blocking Agents Against Tumor Necrosis Factor Alpha California, 2002 2003
    Corporate Author:
    Division of TB Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC), USA.
    Source:
    MMWR. Morbidity and mortality weekly report. 2004; 53(30):683-6.
    Status:
    current
    File Type:
    Filetype[PDF - 324.82 KB]